nimodipine Tablets, film coated 30 mg, 40 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Venezuela
GMP approvals
Venezuela
Manufacturer #30769
This company is dedicated to providing well-being through effective solutions in various therapeutic areas. Their product portfolio includes prescription medications, over-the-counter drugs, and possibly medical devices and supplements. Key therapy areas appear to be cardiovascular, dermatological, gynecological, respiratory, and pain management (NSAIDs). They prioritize quality by adhering to GMP certifications and actively engage in pharmacovigilance programs to ensure patient safety. While specific dosage forms and patents are not mentioned, their focus on multiple therapeutic areas and diverse product lines suggests a wide reach across the pharmaceutical market in regions like the EU and North America.
Nimodipine is a medication used to prevent migraines and treat ischemic stroke, and subarachnoid hemorrhage. Manufacturers of nimodipine produce it both as a standalone medication, in combination with citicoline. Nimodipine suppliers market it in the form of oral capsules, oral solutions, and intravenous liquids.
The developer and earliest manufacturer of nimodipine is Bayer, who first introduced it into the pharmaceutical market in 1985 under the trade name Nimotop. Currently, the drug is approved in over 60 countries. Other major suppliers of nimodipine globally include Sun Pharmaceuticals, Heritage Pharmaceuticals, Bionpharma, Arbor, Thepharmanetwork, and Sofgen.
Nimodipine suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified nimodipine manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail price per 100 (30mg) capsules of trade name nimodipine is approximately 130,00 EUR, whereas the equivalent amount of generic nimodipine tablets costs around 50,00 EUR to 60,00 EUR. A single vial of trade name 10mg/50ml nimodipine injectable solution costs around 20,00 EUR.